322 related articles for article (PubMed ID: 28018972)
1. Metabolic profiling indicates impaired pyruvate dehydrogenase function in myalgic encephalopathy/chronic fatigue syndrome.
Fluge Ø; Mella O; Bruland O; Risa K; Dyrstad SE; Alme K; Rekeland IG; Sapkota D; Røsland GV; Fosså A; Ktoridou-Valen I; Lunde S; Sørland K; Lien K; Herder I; Thürmer H; Gotaas ME; Baranowska KA; Bohnen LM; Schäfer C; McCann A; Sommerfelt K; Helgeland L; Ueland PM; Dahl O; Tronstad KJ
JCI Insight; 2016 Dec; 1(21):e89376. PubMed ID: 28018972
[TBL] [Abstract][Full Text] [Related]
2. Metabolic Dysfunction in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Not Due to Anti-mitochondrial Antibodies.
Nilsson I; Palmer J; Apostolou E; Gottfries CG; Rizwan M; Dahle C; Rosén A
Front Med (Lausanne); 2020; 7():108. PubMed ID: 32296708
[TBL] [Abstract][Full Text] [Related]
3. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Induced by Repeated Forced Swimming in Mice.
Ohba T; Domoto S; Tanaka M; Nakamura S; Shimazawa M; Hara H
Biol Pharm Bull; 2019; 42(7):1140-1145. PubMed ID: 31257290
[TBL] [Abstract][Full Text] [Related]
4. Bioenergetic and Proteomic Profiling of Immune Cells in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients: An Exploratory Study.
Fernandez-Guerra P; Gonzalez-Ebsen AC; Boonen SE; Courraud J; Gregersen N; Mehlsen J; Palmfeldt J; Olsen RKJ; Brinth LS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209852
[TBL] [Abstract][Full Text] [Related]
5. Suggested pathology of systemic exertion intolerance disease: Impairment of the E
Bohne VJB; Bohne Ø
Med Hypotheses; 2019 Sep; 130():109260. PubMed ID: 31383326
[TBL] [Abstract][Full Text] [Related]
6. Increased nuclear factor-κB and loss of p53 are key mechanisms in Myalgic Encephalomyelitis/chronic fatigue syndrome (ME/CFS).
Morris G; Maes M
Med Hypotheses; 2012 Nov; 79(5):607-13. PubMed ID: 22951418
[TBL] [Abstract][Full Text] [Related]
7. Review of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: an evidence-based approach to diagnosis and management by clinicians.
Bested AC; Marshall LM
Rev Environ Health; 2015; 30(4):223-49. PubMed ID: 26613325
[TBL] [Abstract][Full Text] [Related]
8. Unravelling the nature of postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: the role of elastase, complement C4a and interleukin-1beta.
Nijs J; Van Oosterwijck J; Meeus M; Lambrecht L; Metzger K; Frémont M; Paul L
J Intern Med; 2010 Apr; 267(4):418-35. PubMed ID: 20433584
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory and oxidative and nitrosative stress cascades as new drug targets in myalgic encephalomyelitis and chronic fatigue syndrome.
Maes M
Mod Trends Pharmacopsychiatry; 2013; 28():162-74. PubMed ID: 25224898
[TBL] [Abstract][Full Text] [Related]
10. Pathophysiology of skeletal muscle disturbances in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
Wirth KJ; Scheibenbogen C
J Transl Med; 2021 Apr; 19(1):162. PubMed ID: 33882940
[TBL] [Abstract][Full Text] [Related]
11. Association of biomarkers with health-related quality of life and history of stressors in myalgic encephalomyelitis/chronic fatigue syndrome patients.
Fenouillet E; Vigouroux A; Steinberg JG; Chagvardieff A; Retornaz F; Guieu R; Jammes Y
J Transl Med; 2016 Aug; 14(1):251. PubMed ID: 27580693
[TBL] [Abstract][Full Text] [Related]
12. Epigenetic modifications and glucocorticoid sensitivity in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS).
de Vega WC; Herrera S; Vernon SD; McGowan PO
BMC Med Genomics; 2017 Feb; 10(1):11. PubMed ID: 28231836
[TBL] [Abstract][Full Text] [Related]
13. A review on cognitive behavorial therapy (CBT) and graded exercise therapy (GET) in myalgic encephalomyelitis (ME) / chronic fatigue syndrome (CFS): CBT/GET is not only ineffective and not evidence-based, but also potentially harmful for many patients with ME/CFS.
Twisk FN; Maes M
Neuro Endocrinol Lett; 2009; 30(3):284-99. PubMed ID: 19855350
[TBL] [Abstract][Full Text] [Related]
14. Pain inhibition and postexertional malaise in myalgic encephalomyelitis/chronic fatigue syndrome: an experimental study.
Van Oosterwijck J; Nijs J; Meeus M; Lefever I; Huybrechts L; Lambrecht L; Paul L
J Intern Med; 2010 Sep; 268(3):265-78. PubMed ID: 20412374
[TBL] [Abstract][Full Text] [Related]
15. The Role of Autonomic Function in Exercise-induced Endogenous Analgesia: A Case-control Study in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome and Healthy People.
Oosterwijck JV; Marusic U; De Wandele I; Paul L; Meeus M; Moorkens G; Lambrecht L; Danneels L; Nijs J
Pain Physician; 2017 Mar; 20(3):E389-E399. PubMed ID: 28339438
[TBL] [Abstract][Full Text] [Related]
16. Loss of Transient Receptor Potential Melastatin 3 ion channel function in natural killer cells from Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
Cabanas H; Muraki K; Eaton N; Balinas C; Staines D; Marshall-Gradisnik S
Mol Med; 2018 Aug; 24(1):44. PubMed ID: 30134818
[TBL] [Abstract][Full Text] [Related]
17. Dysregulated Provision of Oxidisable Substrates to the Mitochondria in ME/CFS Lymphoblasts.
Missailidis D; Sanislav O; Allan CY; Smith PK; Annesley SJ; Fisher PR
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669532
[TBL] [Abstract][Full Text] [Related]
18. Understanding Muscle Dysfunction in Chronic Fatigue Syndrome.
Rutherford G; Manning P; Newton JL
J Aging Res; 2016; 2016():2497348. PubMed ID: 26998359
[TBL] [Abstract][Full Text] [Related]
19. Poor sleep quality is associated with greater circulating pro-inflammatory cytokines and severity and frequency of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME) symptoms in women.
Milrad SF; Hall DL; Jutagir DR; Lattie EG; Ironson GH; Wohlgemuth W; Nunez MV; Garcia L; Czaja SJ; Perdomo DM; Fletcher MA; Klimas N; Antoni MH
J Neuroimmunol; 2017 Feb; 303():43-50. PubMed ID: 28038892
[TBL] [Abstract][Full Text] [Related]
20. Inflammatory and cell-mediated immune biomarkers in myalgic encephalomyelitis/chronic fatigue syndrome and depression: inflammatory markers are higher in myalgic encephalomyelitis/chronic fatigue syndrome than in depression.
Maes M; Twisk FN; Ringel K
Psychother Psychosom; 2012; 81(5):286-95. PubMed ID: 22832503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
